NEW YORK, May 4 – Large Scale Biology and Illumina both adopted stockholder rights plans Friday, in a preemptive effort to head off hostile takeover attempts, the companies said.

The actions follow similar moves by several other companies in the last several weeks, and are “usually a clue that things are getting too cheap in the markets,” said Franklin Berger, an analyst with JP Morgan H&Q in New York.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.